← Back to Clinical Trials
Recruiting NCT06698146

NCT06698146 Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06698146
Status Recruiting
Phase
Sponsor Northwestern University
Condition Liver Transplant Surgery
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2025-08-27
Primary Completion 2034-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2025-08-27 with a primary completion date of 2034-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Liver transplantation (LT) has become an accepted treatment for selected patients with unresectable liver metastases due to colorectal cancer (CRLM). The goal of this study is to look at and compare the clinical results of all the different approved methods (living vs. Deceased, whole organ vs. Split, one staged vs. Two staged) used to perform a standard liver transplant procedure for recipients with CRLM. Investigators will look at things like different procedure results, recovery in the hospital, and survival rates one year after the transplant. Investigators will also take blood samples from participants to be used in future research. All the transplant methods the investigators are comparing are standard practices approved by the United Network of Organ Sharing (UNOS).

Eligibility Criteria

Inclusion: 1. All Patients of either gender ≥ 18 years of age who are listed for Liver transplant candidates at Northwestern with liver metastases due to colorectal cancer (CRLM). 2. Subjects must be able to provide informed consent themselves and without the use of a legally authorized representative (LAR), to be determined by the PI or Sub-I at the time of Consent. Exclusion: 1. Adults unable to consent 2. Pregnant Women 3. Certain clinical/surgical/anatomical parameters, at the discretion of the PI.

Contact & Investigator

Central Contact

Yajaira Navarro

✉ a-daud@northwestern.edu

📞 312-694-2092

Frequently Asked Questions

Who can join the NCT06698146 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Transplant Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06698146 currently recruiting?

Yes, NCT06698146 is actively recruiting participants. Contact the research team at a-daud@northwestern.edu for enrollment information.

Where is the NCT06698146 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT06698146 clinical trial?

NCT06698146 is sponsored by Northwestern University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology